LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 6.06 | 84.90 | 768 | 365 | 2.1015 | 1.8457 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 7.77 | 84.90 | 10 | 411 | 0.0243 | -0.6092 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 7.77 | 84.90 | 787 | 411 | 1.9137 | 1.6599 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 7.77 | 84.90 | 880 | 411 | 2.1399 | 1.7937 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 9.47 | 84.90 | 12 | 447 | 0.0268 | -0.5578 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 9.47 | 84.90 | 864 | 447 | 1.9310 | 1.6316 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 9.47 | 84.90 | 935 | 447 | 2.0897 | 1.7197 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 11.18 | 84.90 | 21 | 492 | 0.0427 | -0.4235 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 11.18 | 84.90 | 896 | 492 | 1.8198 | 1.5326 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 11.18 | 84.90 | 7 | 492 | 0.0142 | -0.6262 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 11.18 | 84.90 | 1007 | 492 | 2.0453 | 1.6520 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 12.88 | 84.90 | 39 | 531 | 0.0734 | -0.2548 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 12.88 | 84.90 | 974 | 531 | 1.8343 | 1.5156 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 12.88 | 84.90 | 70 | 531 | 0.1318 | -0.0704 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 12.88 | 84.90 | 1051 | 531 | 1.9793 | 1.5890 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 14.58 | 84.90 | 42 | 663 | 0.0633 | -0.2112 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 14.58 | 84.90 | 1027 | 663 | 1.5481 | 1.3175 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 14.58 | 84.90 | 462 | 663 | 0.6964 | 0.7703 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 14.58 | 84.90 | 1148 | 663 | 1.7305 | 1.4062 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 16.29 | 84.90 | 35 | 766 | 0.0456 | -0.2435 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 16.29 | 84.90 | 1046 | 766 | 1.3640 | 1.2054 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 16.29 | 84.90 | 719 | 766 | 0.9376 | 0.9598 | MN20160318_Q02 | N04 |